NO20006313L - Terapeutiske kombinasjoner omfattende en selektiv östrogenreseptor modulator og paratyroidhormon - Google Patents

Terapeutiske kombinasjoner omfattende en selektiv östrogenreseptor modulator og paratyroidhormon

Info

Publication number
NO20006313L
NO20006313L NO20006313A NO20006313A NO20006313L NO 20006313 L NO20006313 L NO 20006313L NO 20006313 A NO20006313 A NO 20006313A NO 20006313 A NO20006313 A NO 20006313A NO 20006313 L NO20006313 L NO 20006313L
Authority
NO
Norway
Prior art keywords
estrogen receptor
parathyroid hormone
receptor modulator
selective estrogen
therapeutic combinations
Prior art date
Application number
NO20006313A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006313D0 (no
Inventor
Hua Zhu Ke
David Duane Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20006313D0 publication Critical patent/NO20006313D0/no
Publication of NO20006313L publication Critical patent/NO20006313L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
NO20006313A 1998-06-16 2000-12-12 Terapeutiske kombinasjoner omfattende en selektiv östrogenreseptor modulator og paratyroidhormon NO20006313L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8947998P 1998-06-16 1998-06-16
PCT/IB1999/000949 WO1999065482A1 (en) 1998-06-16 1999-05-26 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone

Publications (2)

Publication Number Publication Date
NO20006313D0 NO20006313D0 (no) 2000-12-12
NO20006313L true NO20006313L (no) 2000-12-12

Family

ID=22217879

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006313A NO20006313L (no) 1998-06-16 2000-12-12 Terapeutiske kombinasjoner omfattende en selektiv östrogenreseptor modulator og paratyroidhormon

Country Status (34)

Country Link
US (1) US6132774A (is)
EP (1) EP1094808A1 (is)
JP (1) JP2002518323A (is)
KR (1) KR20010052818A (is)
CN (1) CN1305373A (is)
AP (1) AP9901580A0 (is)
AR (1) AR018867A1 (is)
AU (1) AU3725999A (is)
BG (1) BG105125A (is)
BR (1) BR9911228A (is)
CA (1) CA2335078A1 (is)
CO (1) CO5070584A1 (is)
EA (1) EA200001199A1 (is)
GT (1) GT199900066A (is)
HN (1) HN1999000063A (is)
HR (1) HRP20000858A2 (is)
HU (1) HUP0102759A3 (is)
ID (1) ID26873A (is)
IL (1) IL139588A0 (is)
IS (1) IS5719A (is)
MA (1) MA26649A1 (is)
NO (1) NO20006313L (is)
NZ (1) NZ508039A (is)
OA (1) OA11566A (is)
PA (1) PA8471201A1 (is)
PE (1) PE20000644A1 (is)
PL (1) PL344982A1 (is)
SK (1) SK18922000A3 (is)
TN (1) TNSN99119A1 (is)
TR (1) TR200003567T2 (is)
UA (1) UA60367C2 (is)
WO (1) WO1999065482A1 (is)
YU (1) YU75800A (is)
ZA (1) ZA993972B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
US7829552B2 (en) 2003-11-19 2010-11-09 Metabasis Therapeutics, Inc. Phosphorus-containing thyromimetics
MX2007005137A (es) * 2004-11-23 2007-06-22 Warner Lambert Co Derivados del acido 7-(2h-pyrazol-3-il)-3, 5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de lipidemia.
US7790745B2 (en) 2005-10-21 2010-09-07 Bristol-Myers Squibb Company Tetrahydroisoquinoline LXR Modulators
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
TW201043595A (en) * 2009-03-13 2010-12-16 Organon Nv Tetrahydronaphthalen-2-ol derivatives
DE102010027016A1 (de) 2010-07-09 2012-01-12 Universitätsklinikum Jena Steroid-Styrylfarbstoff-Konjugate zur Simulation und direkten lichtoptischen Detektion des Verhaltens von Steroiden im lebenden biologischen Gewebe und in Gegenwart von steroidbindenden Proteinen
CN111067907A (zh) * 2018-10-18 2020-04-28 常州大学 孕激素在抑制血管内皮生长因子表达中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254595A (en) * 1988-12-23 1993-10-19 Elf Sanofi Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
PE20000644A1 (es) 2000-08-02
TR200003567T2 (tr) 2001-06-21
IL139588A0 (en) 2002-02-10
BG105125A (en) 2001-11-30
OA11566A (en) 2004-05-26
HUP0102759A2 (hu) 2002-03-28
ID26873A (id) 2001-02-15
JP2002518323A (ja) 2002-06-25
IS5719A (is) 2000-11-21
CO5070584A1 (es) 2001-08-28
AU3725999A (en) 2000-01-05
EP1094808A1 (en) 2001-05-02
TNSN99119A1 (fr) 2005-11-10
AP9901580A0 (en) 1999-06-30
NO20006313D0 (no) 2000-12-12
US6132774A (en) 2000-10-17
YU75800A (sh) 2003-12-31
BR9911228A (pt) 2001-02-13
UA60367C2 (uk) 2003-10-15
EA200001199A1 (ru) 2001-04-23
CN1305373A (zh) 2001-07-25
PA8471201A1 (es) 2000-09-29
AR018867A1 (es) 2001-12-12
HUP0102759A3 (en) 2002-12-28
SK18922000A3 (sk) 2001-09-11
KR20010052818A (ko) 2001-06-25
MA26649A1 (fr) 2004-12-20
WO1999065482A1 (en) 1999-12-23
HRP20000858A2 (en) 2001-10-31
CA2335078A1 (en) 1999-12-23
ZA993972B (en) 2000-12-15
PL344982A1 (en) 2001-11-19
GT199900066A (es) 2000-10-31
HN1999000063A (es) 2000-01-12
NZ508039A (en) 2003-03-28

Similar Documents

Publication Publication Date Title
HUP0003100A3 (en) Transaction method using a mobile device and identifier device
DE69839779D1 (de) Einkettige bifunktionelle glykoproteinhormone
NO20001806D0 (no) Pulverfyllingsanordning og fremgangsmåte
NO20020728L (no) Sammensetning omfattende et tramadol materiale og et krampestillende medikament
DK0910996T3 (da) Indretning til fiksering og tilpasning af en matrice til tandbehandling
IL137035A0 (en) Method and device for configuring a link
DK0926158T3 (da) Krystallinsk parathyroidea-hormon
GB9800854D0 (en) A material and device for terminal transaction
NO20006313L (no) Terapeutiske kombinasjoner omfattende en selektiv östrogenreseptor modulator og paratyroidhormon
NO993983L (no) Anordning og system for trådlös kommunikasjon
HUP0002654A3 (en) Device for linking reinforced concrete elements
ZA988022B (en) Pouring device
DK0956022T3 (da) Hormonpræparat indeholdende en østrogenforbindelse og en progestativ forbindelse
DK1068238T3 (da) Integrinheterodimer og subunit deraf
DK0747307T3 (da) Indretning til at overføre et flydedygtigt materiale
GB2323022B (en) A support device
NO20006381D0 (no) Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler
NO20024937D0 (no) Type II gonadotropinfrigjörende hormonreseptor og polynukleotider som koder for dette
GB9710002D0 (en) Pouring device
GB9927215D0 (en) Hormone receptor expression
NO994780D0 (no) FremgangsmÕte og arrangement for et trÕdlöst digitalt radiokommunikasjonssystem
GB2330778B (en) Mobility device
DK0973760T3 (da) Kodaistatiner A, B, C og D, en fremgangsmåde til deres fremstilling og deres anvendelse
GB9813004D0 (en) Positioning device
GB9705990D0 (en) A support device

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application